Pharmacological evaluation and phytochemical profiling of butanol extract of L. edodes with in- silico virtual screening

L. edodes (L. edodes) is the most consumed mushroom in the world and has been well known for its therapeutic potential as an edible and medicinal candidate, it contains dietary fibers, vitamins, proteins, minerals, and carbohydrates. In the current study butanolic extract of mushroom was used to form semisolid butanol extract. The current study aimed to explore biometabolites that might have biological activities in n-butanol extract of L. edodes using FT-IR and GC–MS and LC–MS. The synergistic properties of bioactive compounds were futher assessed by performing different biological assays such as antioxidant, anti-inflammatory and antidiabetic. FTIR spectra showed different functional groups including amide N–H group, Alkane (C-H stretching), and (C = C stretching) groups at different spectrum peaks in the range of 500 cm−1 to 5000 cm−1 respectively. GC–MS profiling of n-butanol extract depicted 34 potent biomolecules among those dimethyl; Morphine, 2TMS derivative; Benzoic acid, methyl ester 1-(2-methoxy-1-methylethoxy)-2-propanol were spotted at highest range. Results indicate that L. edodes n-butanol extract showed a maximum anti-inflammatory potential 91.4% at 300 mg/mL. Antioxidant activity was observed by measuring free radical scavenging activity which is 64.6% at optimized concentration along with good antidiabetic activity. In-silico study executed the biopotential of active ingredient morphine which proved the best docking score (− 7.0 kJ/mol) against aldose reductase. The in-silico drug design analysis was performed on biometabolites detected through GC–MS that might be a potential target for sulfatase-2 to treat ruminated arthritis. Morphine binds more strongly (− 7.9 kJ/mol) than other bioactive constituents indicated. QSAR and ADMET analysis shown that morphine is a good candidates against ruminated arthritis. The current study showed that L. edodes might be used as potent drug molecules to cure multiple ailments. As mushrooms have high bioactivity, they can be used against different diseases and to develop antibacterial drugs based on the current situation in the world in which drug resistance is going to increase due to misuse of antibiotics so new and noval biological active compounds are needed to overcome the situation.


Extraction method
To extract biometabolites from L. edodes n-butanol extraction was performed at 37 °C for 5 days with a ratio of mushroom powders to n-butanol of 1:3 in which 500 g sample soaked in 1500 mL of butanol.Using Whatman No. 1 filter paper, solids were filtered out.n-butanol was removed to yield the semi solid extract from the filtrate by rotary evaporator, and then 7 g of crude extract of L. edodes was obtained.At a concentration of 1 g/mL, the crude was dissolved in dimethyl sulfoxide (DMSO).For this experiment, n-butanol extract was kept at 20 °C in a glass bottle 21 .

FT-IR spectroscopic analysis
Fourier transform infrared spectrophotometers (FT-IR) are highly effective tools for identifying chemical bonds in compounds.The Fourier transform infrared spectroscopy(FT-IR) study of L. edodes n-butanol extract was performed by using the Perkin Elmer spectrometer system to find out characteristic peaks and functional groups at a resolution of 4 cm −1 within peak range of 500-4500 cm −122 .

Gas chromatography-mass spectrometry (GC-MS)
GC-MS analysis was carried out using a 7890A gas chromatograph (Agilent 19091-433HP, USA) and mass spectrophotometer, equipped with a HP-5 MS fused silica column (5% phenyl methyl siloxane, 30 × 250 μm, film thickness 0.25 μm), interfaced with 5675CInert MSD with Triple-Axis detector.With helium gas as the carrier gas, the column velocity was set to 1.0 mL/min.In addition to the GC-MS parameters, the ion source temperature is 250 °C, the interface temperature is 300 °C, the pressure is 16.2 psi, and the out-time is 1.8 mm.Special parameters include a split ratio of 1:50 with a 300 °C interface temperature, and another data point is the temperature of the interface.Within five minutes of being maintained at 36 ºC, the temperature of the column increased gradually from 36 to 150 ºC.A temperature increased up to 20 °C/minute for five minutes was used to reach 250 °C.The elution took 47.5 min to complete.By comparing each component's average peak area with its total area, we calculated its percentage amount.Data was collected using The supplier used MS Solution software for controlling and monitoring the system 21 .These compounds can be identified using NIST MS 2.0 libraries.

Column chromatography
Butanolic extract was further fractionated to purify biological active compounds by loading silica gel 400-600 µm pore size in a glass column by selecting different solvents to set polarities according to the nature of the fraction to collect the column fraction for further purification of secondary metabolites by passing extract through the column.Partially purified biometabolites were determined in the collected fraction by finding out their retention time, percentage area, molecular weight and monoisotpoic mass by performing LC-MS analysis.

LC-MS analysis
LC-MS was employed for non-volatile and high molecular weight bioactive compounds in the n-butanol extract passed through the column.A triple quadrupole liquid chromatography-mass spectrometry system (Finnigan TSQ Quantum Ultra EMR, Thermo Scientific) was employed in the study 23 .

Biological activities
In vitro anti-inflammatory potential A slightly modified standard protocol was used to test in-vitro anti-inflammatory potential 24 .The protein denaturation inhibition method was used to study L. edodes n-butanol extract.To adjust pH from 8.53 to 6.74, Bovine serum albumin (BSA) (0.4%) was dissolved in tris buffer saline with glacial acetic acid 25 .The reaction mixture consisted of BSA (0.2 mL), 1X PBS (Phosphate-Buffered Saline) (2.8 mL) (pH: 6.4), and each mushroom extract (2 mL) in varying concentrations of 100,150,200,250 and 300 mg/mL.A similar volume of distilled water was used as a control.Incubation of the mixture at 37 °C for 15 min was followed by heating on a water bath for 5 min at 70 °C.Samples were cooled before being measured at 660 nm.A reference drug that was used in this study was diclofenac sodium (1 mg/mL).Using the following formula calculate the percentage of protein denaturation inhibition:  26 .The reaction mixture contained 0.5 mL of extract, 3 mL of butanol, and 0.3 mL of 0.5 mM 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical solution in methanol.An absorbance measurement at 517 nm was performed after incubation for 45 min.
The following equation was used to calculate antioxidant activity.

Anti-diabetic activity
The protocol given by Dessalegn et al., 2019 indicated to possess antidiabetic activity by DNSA (3,5-dinitrosalicylic acid) assay at different concentrations (100,150,200,250,300 mg/mL) of L. edodes n-butanol extract.200 µL extract of n-butanol is mixed with 200 uL α-Amylase solution.A reaction mixture was incubated at 25 °C for 10 min.After incubation, 200 µL of 1% starch solution was added and the mixture was incubated for another 10 min.Following this, 400 µL of DNSA solution is added and the absorbance of the mixture is measured by ELISA at 630 nm.Metformin was used as the standard and distilled water as a negative control 27 .

Preparation of ligand
Lipinski's rules were used to predict 25 compounds Based on docking.Pub Chem compound database was used to derive the structures of the bioactive compound.

Target protein retrieval
The selection of aldose reductase (PDB ID: 2FZD) for diabetic activity and Cadherin-11 (PDB ID: 6CGB) for arthritis was based on their interaction with L.edodoe bioactive molecules.From the Protein Data Bank (PDB) and retrieved the 3D crystal structures of the proteins.

Target protein preparation
In this study, proteins were processed, prepared, and converted into protein models using Discovery Studio software.As a result of removing water molecules from the structures, protein structures were determined by X-ray crystallography.Moreover, Discovery Studio software was used to identify potential binding sites for potential compounds, which could lead to further advancements in drug discovery.

Docking.
The ligands and target proteins were docked using AutoDock Vina..

Deformability, B-factor, and covariance computation
Molecular dynamic simulation complexes have been analyzed for deformability, B-factor, covariance, and rootmean-square fluctuations to determine any residues that remain unstable or deformed after coarse-grained simulations.A deformability analysis, B-factor analysis, and covariance analysis were performed using IMODS software 30 .

ADMET study
Using ChemDraw Ultra 8.0, the structures of selected compounds were illustrated to analyze their pharmacokinetics (absorption, distribution, metabolism, and excretion).To predict the drug-like and pharmacokinetic properties of the selected compounds, the legends were converted into SMILES format and the ADME tool was used by an online server (http:// www.swiss adme..

Statistical analysis
The results are revealed as Mean SD in the Figures.A two-way ANOVA was performed using Graph Pad Prism (San Diego, CA, USA) software.The graphs' values are all shown as mean SE. p < 0.05 and p < 0.001 (***) when compared to the control, respectively.

Ethical approval
All the methods were performed in accordance whit relevant institutional guidelines and regulations.

FT-IR analysis
The presence of functional groups was subsequently confirmed using FT-IR analysis.FT-IR spectrum in Fig. 1 showed transmittance and wavelength values, transmittance give the quantitative analysis and physical meaning to show the functional group.FT-IR spectra of n-butanol extract contain the presence of the N-H stretching group at 3352.70 cm −1 and carbonyl (C-H stretching) group at 2959.11 cm −1 , 2931.96 cm −1 and 2873.67 cm −1 while at 1727.68 cm −1 (C = O stretching) shown in Fig. 1.

LC-MS analysis
Butanol extract was passed through silica gel column to attain column fraction for partial purfication of bioactive compounds intital screening was carried out by performing Thin Layer Chromatography before subjected to LC-MS.The results of LC-MS analysis of the n-butanol extract of L. edodes illustrated the presence of total four different phytoconstituents at different retention times.Phytoconstituents were identified through LC-MS that might be responsible for pharmacological activities.The compounds were recognized based on retention time and molecular mass by comparing with Mass Bank Data Base and HMDB.The LC-MS chromatogram detected compounds of n-butanol extract of L. edodes of the detected compounds shown in (Figure 3).It was observed that the different peaks were obtained at different retention times.In this, the highest peak is at the retention time of 13.077, 11.858 followed by 4.120, 2.477 belonging to the compound acid Clocapramine, 4-Amino-5-hydroxy-2,7-naphthalenedisulfonic, Loperamide oxide and Malonic acid (Table 2).
Malonic acid is a dicarboxylic acid with structure.Malonates are ionized forms of malonic acid, as well as its esters and salts.The compound malonic acid is used to prepare cinnamic acid, which is used to make cin metacin, an anti-inflammatory compound.
This compound belongs to the class of organic compounds known as diphenylmethanes with peak number 10.It is used as an anti-inflammatory.
4-Amino-5-hydroxy-2,7-naphthalenedisulfonic acid 2-naphthalenesulfonic acid substituted with an amino group at position 7 and a hydroxy group at position 4 is known as an aminonaphthalenesulfonic acid.It has a role as a metabolite.As a member of the naphthol family, it is an aminonaphthalenesulfonic acid.Clomipramine is a tricyclic compound detected in n-butanol subfraction with peak number 40 with 481 molecular weight with product ions of 37,174 and 114.

Anti-inflammatory
The present study demonstrated the anti-inflammatory potential of n-butanol extract of L. edodes on denaturation of protein inhibition in vitro, as shown in Fig. 4. As a result of 300 mg/mL concentration, 91.4% inhibition was measured, which is similar to 97.9% inhibition measured with the positive control (Diclofenac sodium).In the n-butanol extract, 75.3% inhibition was observed at a concentration of 100 mg/mL shown in Fig. 4. www.nature.com/scientificreports/

Antioxidant activity
The n-butanol extract of L. edodes was analyzed for antioxidant potential by DPPH.Results showed that the scavenging activity of n-butanol extract on antioxidant assay was concentration dependent i.e., increases with increasing concentration (100-300 mg/mL).The maximum concentration was 64.6% as compared to the positive control (ascorbic acid) which was shown in Fig. 5.

Anti-diabetic activity
This study analyzed the n-butanol extract for α-amylase enzyme inhibition by DNSA and starch iodine assay.The concentration of L. edodes n-butanol depended on the inhibition of α-amylase shown in Fig. 6.The butanol crude extract showed maximum inhibition at 300 mg/mL (74.98%), indicating anti-diabetic potential.As the concentration decreases, the anti-diabetic activity also decreases and is minimal at the lowest concentration.The positive control metformin showed a maximum (97.6%) at 300 mg/mL concentration, as shown in Fig. 6.

In-silico anti-diabetic activities with Aldose Reductase
Molecular docking of compounds with aldose reductase (PDB ID: 2FZD) was performed, and results show that the morphine and N,N,N-trimethyl-histidine have the highest binding affinity 7.0 and − 5.7, respectively (Fig. 7) and highest binding scores compounds were given in Table 3. www.nature.com/scientificreports/

Molecular docking
The molecular docking of five compounds was performed with targeted arthritis protein cadherin-11 and sulfatase-2 docking scores Fig. 8 and Fig. 9.Among all compounds, Morphine and N,N, N-trimethyl-histidine show high docking energy − 7.9 and − 7.5 against sulfatase-2 respectively Morphine and Oxazepam show high docking energy − 8.0 and − 6.5 shown in Fig. 8 and Table .4.  www.nature.com/scientificreports/

IMODS simulations
Molecular dynamic simulation By using the force field of the complex concerning a time interval, iMods simulates the molecular dynamics of the complex.At each level of residue capacity, the complex model displays less deformation.The Eigenvalue of Cadherin-11 complex is 2.80269e-05.As illustrated in the Figure, residues in a highly related region with low RMSD exhibit a better interaction as a result of the molecular dynamic simulation shown in Fig. 10.www.nature.com/scientificreports/

QSAR Modeling
Using Cloud 3D-QSAR, we modeled 3D QSAR in biological systems and analyzed the relationships between molecules and their behavior.Each ligand or compound in the dataset had an IC50 value determined manually in nm.All compounds give a higher r20.9993 and a smaller q2 − 0.80663 than model number 7 morphine.A steric hindrance analysis and electrostatic interaction force were conducted to obtain the results.Moreover, it determines the pKi value of compounds, and experimental data indicates that morphine is the most effective ligand.The graphical representation of data and the contour map structure of the best drug candidate are shown in Fig. 12.

Discussion
Mushrooms have been used as medicines by humans for at least 5,000 years 33 globally, the prevalence of diseases is increasing due to two main factors: inadequate nutrition associated with modern lifestyles and an increase in average life expectancy 34 .Secondary metabolites derived from medicinal mushrooms have a key role in improving health status from ancient times in Asian medicine.Numerous mushroom species have been used to treat immune-based diseases, such as Multiple Sclerosis (MS) 35 .There are several secondary metabolites present in mushrooms that can be used therapeutically, such as lactones, terpenoids, alkaloids, antibiotics, and metal-chelating agents 36,37 .FT-IR spectrum of n-butanol extract shows different functional groups including N-H stretching group, Alkane (C-H stretching) group, (C = O stretching) shown in Fig. 1. 0.GCMS analysis showed 35 biometabolites among these Morphine, oxazepan and N,N,N-trimethyl-histidine is highly significant .The present study also indicates the presence of 2-Pyrrolidinone (12.40%).Silane, [(1,1-dimethyl-2 propenyl) oxy] dimethyl (5.12%); Morphine, 2TMS derivative (0.86%); Benzoic acid, methyl ester 1-(2-methoxy-1-methylethoxy)-2-propanol (2.55%), present in the fruiting bodies of mushroom L. edodes that demonstrated in Fig. 2 and Table 1.Previous cited literature showed L. edodes have potential biometabolites which might be responsible for biological potential.Previous studies correlate with current study which explained 297 different metabolites of two strains of L. edodes with different tolerances at different durations of high temperature including amino acids, sugars and glycols like Proline, Gallic acid, 3-Hydroxypropionic acid, Dibenzofuran, Aminomalonic acid, Oxalic acid which indeed is good agreement with present study 38 .There was a higher percentage composition associated with the different biological activities among the bioactive components.Although inflammation serves a protective role, many diseases, such as atherosclerosis, arthritis, cancer, and ischemic heart disease, have etiological causes in inflammatory processes 1 .The purpose of this study was to investigate the anti-inflammatory properties of n-butanol mushroom extracts and their bioactive metabolites.According to the results, n-butanol has excellent anti-inflammatory activity at 91.4% as at 300 mg/mL, GC-MS-based identified metabolites showed an impressive maximum inhibitory concentration (91.4%) in comparison with the positive control Diclofenac sodium that showed a higher percent stabilization, at 97.9%.Previous cited literature also showed that mushroom species have significant anti-inflammatory potential 39 .Living conditions and organisms can be reflected in the metabolism.As metabolite detection and identification methods continue to advance, interest in metabolic control in response to abiotic stress has grown significantly.Numerous studies have focused on the role of metabonomics in the defence mechanism in challenging conditions, mostly using some model plants, crop varieties, and yeasts in fungus 40,41 .
In previous study, sophisticated GC-MS metabonomics conducted both domestically and internationally yielded metabolites.Using a Venn diagram to intersect differential metabolites that were significantly altered in each treatment, 74 metabolites with notable variations in 18 species of mushrooms were found, but the mutant strain 18N44 included 106 significant differential metabolites 42 .Following a thorough analysis of the two strains, 47  important differential metabolites that underwent significant alteration were identified.By using KEGG mapping, several maps of metabolic pathways were produced.Pathway enrichment analysis identified five different metabolic pathways.Amino acids, sugars or glycols, intermediate products of glycolysis, and the TCA cycle were the primary enriched compounds.In this study, 35 metabolites were identified in L. edodes mushrooms, they play an important role in the metabolism of living organisms such as amino acid, sugar or glycols, intermediated products of glycolysis and TCA cycle of living organism 42 .Butanolic extract was further fractionated to purify biological active compounds by loading silica gel 400-600 µm pore size in a glass column by selecting different solvents to set polarities according to the nature of the fraction to collect the column fraction for further purification of secondary metabolites by passing extract through the column.Partially purified biometabolites were determined in the collected fraction by performing LC-MS.LC-MS investigation was accomplished for determination of high molecular weight and nonvolatile bioactive compounds in the n-butanol extract passed through column chromatography.Present results depicted different peaks at different retention times showed valuable biometabolites including Clocapramine, 4-Amino-5-hydroxy-2,7-naphthalenedisulfonic, Loperamide oxide and Malonic acid illustrated in above Table 2. Previous literature showed significant amount of bioactive compounds in different mushrooms species 43 .Above said      activities 4-Amino-5-hydroxy-2, 7-naphthalenedisulfonic acid possess antioxidant, anti-inflammatory and anticancerous activity while Malonic acid as anti-inflammatory and antioxidant effect 45 .
As a comparison to the previous literature 15 , our results impacted good anti-inflammatory activity.Most diseases in humans are caused by the accumulation of free radicals.Antioxidants are responsible for scavenging free radicals and minimizing their destructive effects 16 .In the human body, reactive oxygen species are constantly formed by metabolism and diseases, resulting in the damage of tissues and causing degenerative diseases and extensive lysis of tissues.To overcome oxidative damage, there are several synthetic drugs available that can be used, but these drugs are associated with many adverse side effects.Alternative solutions to such side effects include consuming natural antioxidants in the form of food supplements and traditional medicine to avoid these side effects 46 .The current study was appraised to investigate the antioxidant potential of n-butanol extracts of shiitake mushroom (L.edodes) to protect the body from free radicals.The n-butanol extract of L. edodes at 300 mg/mL was shown in Fig. 5 to have a significant inhibitory potential (64%),that indicates the potent antioxidant behavior of the secondary metabolites.Previous cited literature correlated with current study showed significant antioxidant potential in L. edodes prepared extract which is 45-90% of ethanolic extract 39 .The presence of β-glucans and phenolic compounds in Lentinus edodes suggests this mushroom could be a suitable candidate for nutritional supplementation 47 .The medicinal properties of edible mushrooms include antitumor activity related to their β-D-glucan content; and antidiabetic from decreasing blood glucose due to the presence of bioactive substances (including phenolics and ergothioneine) 48 .
The biological assay was conducted with n-butanol extract, which showed 74% anti-diabetic activity at 300 mg/mL.This study was performed to evaluate the antidiabetic effects of extracts in vitro and in silico analysis.Morphine shows the best anti-diabetic compound against Aldose reductase and thus was proved from molecular docking.The reported study shows that the analgesic effect of morphine is reduced in hyperglycemia, based on experimental and clinical observations which is 60-82% 49 .An inflammatory disorder with a high mortality rate, rheumatoid arthritis is considered a systemic inflammatory disorder.The prevalence of RA has increased the economic burden, despite the persistent reduction in RA mortality.It's an autoimmune chronic degenerative disease that affects joints and extra-articular tissue 50 Extracellular sulfatase-2 (Sulf-2) influences receptor-ligand binding and subsequent signaling by chemokines and growth factors, although its role in inflammatory cytokine signaling in Rheumatoid arthritis (RA) has not been explored 51 .
Drug discovery in the modern era is most commonly achieved through computer-aided drug design (CADD) 52 .Molecular docking is a method of predicting the experimental binding affinity of inhibitors (ligands) to proteins.Drug-likeness reveals the potential suitability of a ligand for a biological system, whereas molecular docking reveals the interaction of ligands with active sites of protein 53 .Docking was done against sulfatase-2 and cadherin-11 the high score showed good interaction between morphine and the receptor that demonstrated in Table 4.The current docking results are similar with previous study reported by 54 .Those results show morphine is effective against arthritis.
Drug development and agrochemical design have benefited from quantitative structure-activity relationships (QSAR) 55 .QSAR can be used to design drugs using genetic algorithms and evolutionary algorithms.Research has shown that the many applications of QSAR are identification and conformation searches of QSARs, receptor docking, variable selection, and pharmacophore and receptor elucidation.The R2 QSAR value (0.9993) and Q2 (− 0.8066) analysis of the good value ligand.Normal mode analysis mobility reveals the large-scale B-factor and mobility as well as the stability of the molecules.Further molecular simulation (MD) exposed the internal coordinate's analysis depending on the protein-ligand structural interactions 56 .IMODS simulations were performed for the top first compounds of cadherine-11 to assess the stability of the docked complexes between phytochemicals and proteins through strong hydrogen bonds, as shown in Fig. 9. Based on ADME and drug-like properties, the molecules are moderately bioavailable through the gastrointestinal tract, but not permeable through the brain.In the bioavailability radar, six physicochemical properties of a drug are considered: saturation, Fig. www.nature.com/scientificreports/BOILED-egg image of morphine complex.In the yellow region, brain penetration was high, the white region was high, and the red dot showed that the compound wasn't a substrate of the P-gps because of their polarity, flexibility, size, lipophilicity, and solubility.It appears that morphine may be beneficial for ruminated arthritis under In silico analysis.The ADME and drug-like properties of morphine is highly potential against different ailments which was previously reported studies [57][58][59][60] .Clinical breakthroughs in the treatment and prevention of infectious diseases are being achieved through the targeting of bacterial diseases.Further research into these potential targets is necessary in order to identify novel approaches to the development of future drugs and treatments.

Conclusion
The findings of this study revealed the possible use of L. edodes butanolic extract in food and nutraceutical applications such as anti-inflammatory, antioxidant and anti-diabetic which might be possible due to presence of active biometabolites.FT-IR, GC-MS and LC-MS were used to detect these bioactive compounds and their therapeutic potential was further assessed by molecular docking principles following an insilico approach for n-butanol extracts.In which 15 compounds were docked out of which 10 gives best possible binding energies.
In silico virtual screening showed that morphine is effective against ruminated arthritis.The results show that the extract contains a wide range of bioactive compounds, which may be beneficial for various therapeutic applications Therefore mushrooms butanolic extracts is an ideal candidate for developing new drugs to combat emerging pathogenic bacteria, to tackle the global healthcare crisis.

Figure 6 .
Figure 6.Antidiabetic activity of L. edodes n-butanol extract.The vertical bar represents Mean ± SD.The values are expressed in the Mean ± SD of triplicates and all values were statistically significant p < 0.05 (*).

Figure 9 .
Figure 9. Molecular docking of cadherin -11 protein of arthritis with bioactive compounds (a) shows the 3D image of morphine (b) shows the 2D image of morphine (c) 3D image of N,N,N-Trimethyl-Histidine (d) 2D image of N,N,N-Trimethyl-Histidine.
Formic acid, (2-methylphenyl)methyl ester − 5.4 − 5.2 5,6-Diamino-1,3-dimethyluracil − 5.3 − 5.9 D-Glycero-D-galacto-heptose − 5.1 − 4.9 study correlate with previous literature which showed LC-MS analysis of brown film of L. edodes mycelia which depicted total of 236 nonrepetitive different metabolites, in which 61 were common differential metabolites.Many differential metabolites were first identified by means of an untargeted LC-MS-based metabolomics approach in the brown filem of L. edodes, which also shows the variety and richness of the metabolites in brown film of L. edodes 44 .Previous cited literature illustrated these bioactive compounds possess significant pharmacological

Figure 10 .
Figure 10.In this Molecular Dynamics simulation, morphine docked with sulfatase-2 (a) depicts the compound docked (b) indicates the structure has low deformability (c) shows the B-factor, (d) Eigenvalues are shown, and (e) shows the variance explained in green and red (f) and (g) show the covariance and elastic network of the complex.

Figure 11 .
Figure 11.A morphine compound was analyzed in a boiled showed the dependence of lipophilicity on the polarity of the studied molecules.

( 10 )Figure 12 .
Figure 12.The QSAR cloud shows the following results (a) a Contour map of the compound (morphine) (b) Graphical representation of data of bioactive compounds.

Table 1 .
Metabolites identified from L. edodes n-butanol extract by GCMS analysis.

Table 2 .
LC-MS analysis of n-butanol extract of L. edodes. Sr.
After docking results, SwissADME characterized the compounds with the highest inhibitory affinity against Cadherin-11.It is used to determine the toxicity and properties of a compound.It is possible to calculate logS and logP as well as different other drug-likeness rules using Swiss ADME's multiple calculation approaches.In comparison to all compounds, morphine achieved the highest docking score and ADMET properties of − 2.30, with excellent water solubility and low GI absorption.The drug analysis shows that Lipinski and Veber's rule applies.The analysis of BOILED eggs is shown in Fig.11.ButanolPosiƟve control Figure 5. Free DPPH radical scavenging activity of n-butanol extract of L. edodes.The vertical bar represents Mean ± SD.The values are expressed in the mean ± SD of triplicates and all values were statistically significant p < 0.05 (*).Vol:.(1234567890)Scientific Reports | (2024) 14:5751 | https://doi.org/10.1038/s41598-024-56421-7